Literature DB >> 8436171

Only a small proportion of splenic B cells in adults are short-lived virgin cells.

E Y Chan1, I C MacLennan.   

Abstract

A cohort of newly produced virgin B cells was followed from the marrow to the spleen of non-immunized clean rats, which showed minimal antigen-driven proliferation of B cells in their spleens. The progenitors of this cohort of virgin cells were labeled in vivo over 12 h with the thymidine analogue 5-bromo-2'-deoxyuridine (BrdUrd) and their non proliferating progeny left the marrow 2-3 days later. This coincided with the arrival of labeled B cells in the red pulp and T zones of the spleen. These appear to be short-lived as few remained a week after the label was given. The short-lived newly produced virgin B cells can only comprise a minority of splenic B cells, for it is shown that only 20% of splenic B cells are found in the red pulp and T zone. It is calculated that newly produced virgin B cells are likely to make up between 5% and 10% of splenic B cells. In the marginal zones and follicular mantle respective medians of 3.3% and 1.8% were already labeled at 1 day from the start of the BrdUrd pulse. The appearance of these cells seems likely to result from antigen-driven B cell proliferation outside the marrow, for labeled virgin B cells have not started to leave the marrow at this stage. During day 2 and 3 the proportion of labeled follicular mantle B cells rose to 3.4%, which might in part reflect the recruitment of newly produced virgin B cells to the pool of recirculating follicular B cells. After day 3 in the follicles and day 1 in the marginal zones the proportion of labeled cells did not vary significantly through day 7. This appears to confirm the comparative longevity of the cells in these zones, which contain 80% of the non-proliferating splenic B cells of adult rats.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436171     DOI: 10.1002/eji.1830230209

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  CD4+ T cells derived from B cell-deficient mice inhibit the establishment of peripheral B cell pools.

Authors:  N Baumgarth; G C Jager; O C Herman; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

Review 2.  Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

Authors:  C C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

Review 3.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1996-08

Review 4.  Lifespan of lymphocytes.

Authors:  D F Tough; J Sprent
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

Review 5.  Self-reactive B cells in nonautoimmune and autoimmune mice.

Authors:  J Erikson; L Mandik; A Bui; A Eaton; H Noorchashm; K A Nguyen; J H Roark
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

6.  Viral superantigen drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production.

Authors:  S A Luther; A Gulbranson-Judge; H Acha-Orbea; I C MacLennan
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

7.  Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool.

Authors:  M Turner; A Gulbranson-Judge; M E Quinn; A E Walters; I C MacLennan; V L Tybulewicz
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

8.  Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle.

Authors:  L Mandik-Nayak; A Bui; H Noorchashm; A Eaton; J Erikson
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

9.  Immune response to SARS-CoV-2 in severe disease and long COVID-19.

Authors:  Tomonari Sumi; Kouji Harada
Journal:  iScience       Date:  2022-07-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.